NFKB1 and neoplasm: Delaying CD24-Fc administration at the time of the booster would theoretically have the desired effect of suppressing DAMPs, limiting non-specific tissue damage and suppressing inflammation through blockade of NF-κB activation (8) without suppressing the anti-tumor effect.